Seneschal Advisors’s ResMed RMD Stock Holding History

Seneschal Advisors’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$390	Hold	2	–	–	﹤0.01%	450
2026 Q1	$449	Hold	2	–	–	﹤0.01%	391
2025 Q4	$482	Hold	2	–	–	﹤0.01%	367
2025 Q3	$548	Buy	+2	New	+$546	﹤0.01%	340

Other funds holding RMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Seneschal Advisors's RMD Position: Q2 2026 in Review

Seneschal Advisors held its ResMed (RMD) position steady in Q2 2026 at 2 shares worth $390. The position accounts for ﹤0.01% of the portfolio, ranked #450.

Seneschal Advisors first reported a position in RMD in Q3 2025 and has held it in 4 quarters since. The position peaked at $548 in Q3 2025. 888 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

Seneschal Advisors held 2 shares of ResMed worth $390 as of Q2 2026.
Seneschal Advisors left its ResMed share count unchanged in Q2 2026.
ResMed made up ﹤0.01% of Seneschal Advisors's portfolio in Q2 2026, its #450 holding.
Seneschal Advisors first reported a position in ResMed in Q3 2025 and has held it in 4 quarters since.
Seneschal Advisors's ResMed position peaked at $548 in Q3 2025.
888 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Seneschal Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.